ISSN 1674-3865  CN 21-1569/R
主管:国家卫生健康委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

中国中西医结合儿科学 ›› 2026, Vol. 18 ›› Issue (2): 141-146.doi: 10.20274/j.cnki.issn.1674-3865.2026.02.010

• 中医应用研究 • 上一篇    下一篇

郑健教授基于“分期协同、序贯增效”原则辨治儿童难治性肾病综合征的经验撷要

陈美芳1,2, 郑健1,3()   

  1. 350004 福州,福建中医药大学附属人民医院儿科(陈美芳,郑健)
    350122 福州,福建中医药大学中医儿科研究所(郑健)
    350122 福州,福建中医药大学2023级中医儿科学专业研究生(陈美芳)
  • 收稿日期:2025-12-15 修回日期:2026-01-07 出版日期:2026-04-25 上线日期:2026-04-25
  • 通讯作者: 郑健 E-mail:zhengjian7816@126.com
  • 作者简介:陈美芳(1999-),女,福建中医药大学2023级硕士研究生在读。研究方向:儿童肾脏病的中西医结合研究
  • 基金资助:
    国家中医药管理局高水平中医药重点学科建设项目-中西医结合临床(zyyzdxk-2023104);郑健全国名老中医药专家传承工作室建设项目(2022075)

Professor Zheng Jian's experience in treating refractory nephrotic syndrome in children based on the principle of "phased collaboration and sequential synergy"

Meifang CHEN1,2, Jian ZHENG1,3()   

  1. 1.The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine,Fuzhou 350004,China
    2.Fujian University of Traditional Chinese Medicine,Fuzhou 350122, China
    3.Institute of Pediatrics of Chinese Medicine, Fujian University of Traditional Chinese Medicine,Fuzhou 350122, China
  • Received:2025-12-15 Revised:2026-01-07 Published:2026-04-25 Online:2026-04-25
  • Contact: Jian ZHENG E-mail:zhengjian7816@126.com
  • Supported by:
    State Administration of Traditional Chinese Medicine High-level Key Discipline Construction Project of Traditional Chinese Medicine-Clinical Combination of Chinese and Western Medicine(ZYYZDXK-2023104)

摘要:

本文总结了郑健教授治疗难治性肾病综合征(RNS)的学术思想与临证经验,重点梳理了其采用中药联合利妥昔单抗(RTX)治疗RNS的中西医结合方案。该方案以病证结合厘清病机为核心,确立了分期论治的治疗策略,通过健脾补肾以固其本、活血利湿以治其标,并依据疾病的不同阶段及RTX作用特点动态调整中药组方,从而发挥中西药协同、减毒增效的作用。临床实践证明,此方案能显著增强RTX疗效,降低不良反应及RNS复发率,为RNS的中西医结合治疗提供了有效参考。

关键词: 难治性肾病综合征, 利妥昔单抗, 中西医结合, 名医经验, 儿童

Abstract:

This paper summarizes Professor Zheng Jian's academic thought and clinical experience in treating refractory nephrotic syndrome (RNS), focusing on his integrated traditional Chinese and western medicine scheme of treating RNS with traditional Chinese medicine and rituximab (RTX). Based on the combination of disease and syndrome and clarification of pathogenesis, a strategy of treatment by stages is established in the scheme, which consolidates the foundation by strengthening the spleen and tonifying the kidney and deals with its symptoms by promoting blood circulation and eliminating dampness, and dynamically adjusts the traditional Chinese medicine prescriptions according to the different stages of the disease and the characteristics of RTX, so as to leverage the synergistic effects of integrated traditional Chinese and western medicine to reduce toxicity and enhance efficacy. Clinical practice has proved that this scheme can significantly enhance the efficacy of RTX, reduce adverse reactions and recurrence rate of RNS, and provide an effective reference for the treatment of RNS with integrated traditional Chinese and western medicine.

Key words: Refractory nephrotic syndrome, Rituximab, Integrated traditional Chinese and western medicine, Famous doctor experience, Child

中图分类号: